Forward Look

Experts say it's necessary to look behind the statistics.

by Delia O’Hara

Forward Look

A new way to identify a cancer recurrence.

by Bradley Jones

Policy Matters

The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

Healthy Habits

Drinking at any level increases cancer risk.

by Ashley P. Taylor

With recent advances in targeted treatments, people diagnosed with chronic lymphocytic leukemia have more options to manage the disease.

by Kendall K. Morgan

From the Editor-in-Chief

Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

by William G. Nelson, MD, PhD

Forward Look

Christine Ambrosone on what her research shows.

by Sue Rochman

Forward Look

As patents expire on biologic drugs, cancer patients get new options.

by Stephen Ornes

Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

by Sue Rochman

An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.

by Anna Azvolinsky